Header Logo

Connection

Jerrold Meyer to Hallucinogens

This is a "connection" page, showing publications Jerrold Meyer has written about Hallucinogens.
Connection Strength

1.123
  1. Biezonski DK, Meyer JS. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb; 112(4):951-62.
    View in: PubMed
    Score: 0.337
  2. Piper BJ, Farelli JD, Meyer JS. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats. Dev Neurosci. 2009; 31(1-2):90-4.
    View in: PubMed
    Score: 0.323
  3. Meyer JS, Brevard ME, Piper BJ, Ali SF, Ferris CF. Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. Ann N Y Acad Sci. 2006 Aug; 1074:365-76.
    View in: PubMed
    Score: 0.268
  4. Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology. 2008 Apr; 33(5):1192-205.
    View in: PubMed
    Score: 0.071
  5. Brevard ME, Meyer JS, Harder JA, Ferris CF. Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy"). Magn Reson Imaging. 2006 Jul; 24(6):707-14.
    View in: PubMed
    Score: 0.066
  6. Meyer JS, Grande M, Johnson K, Ali SF. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats. Int J Dev Neurosci. 2004 Aug-Oct; 22(5-6):261-71.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.